Connection

Jan Basile to Antihypertensive Agents

Back to Details
This is a "connection" page, showing publications Jan Basile has written about Antihypertensive Agents.
Jan Basile
Connection Strength
5.954
Antihypertensive Agents
  1. Analysis of recent papers in hypertension treatment of hypertension in the setting of acute intracerebral hemorrhage: still no clear answer on the best BP level to intervene or what BP goal to achieve. J Clin Hypertens (Greenwich). 2014 Jan; 16(1):1-3.
    View in: PubMed
    Score: 0.330
  2. Analysis of recent papers in hypertension: nighttime administration of at least one antihypertensive medication is associated with better blood pressure control and cardiovascular outcomes in patients with type 2 diabetes or chronic kidney disease. J Clin Hypertens (Greenwich). 2013 Jan; 15(1):2-4.
    View in: PubMed
    Score: 0.305
  3. The Rheos Pivotol trial evaluating baroreflex activation therapy fails to meet efficacy and safety end points in resistant hypertension: back to the drawing board. J Clin Hypertens (Greenwich). 2012 Mar; 14(3):184-6.
    View in: PubMed
    Score: 0.289
  4. Comparison of aliskiren/hydrochlorothiazide combination therapy with hydrochlorothiazide monotherapy in older patients with stage 2 systolic hypertension: results of the ACTION study. J Clin Hypertens (Greenwich). 2011 Mar; 13(3):162-9.
    View in: PubMed
    Score: 0.270
  5. Treating the black hypertensive in 2010: achieve lower targets while awaiting more definitive evidence. J Clin Hypertens (Greenwich). 2011 Jan; 13(1):1-4.
    View in: PubMed
    Score: 0.268
  6. Combination angiotensin receptor blocker-neutral endopeptidase inhibitor provides additive blood pressure reduction over angiotensin receptor blocker alone. J Clin Hypertens (Greenwich). 2010 Oct; 12(10):809-12.
    View in: PubMed
    Score: 0.262
  7. Is there accord in ACCORD? Lower blood pressure targets in type 2 diabetes does not lead to fewer cardiovascular events except for reductions in stroke. J Clin Hypertens (Greenwich). 2010 Jul 01; 12(7):472-7.
    View in: PubMed
    Score: 0.260
  8. Identifying and managing factors that interfere with or worsen blood pressure control. Postgrad Med. 2010 Mar; 122(2):35-48.
    View in: PubMed
    Score: 0.254
  9. Largest meta-analysis to date suggests that patients at risk for cardiovascular disease events derive benefit from antihypertensive therapy regardless of baseline blood pressure and to reduce vascular events, lowering blood pressure is more important than choice of antihypertensive drug class. J Clin Hypertens (Greenwich). 2009 Dec; 11(12):743-5.
    View in: PubMed
    Score: 0.249
  10. Antihypertensive therapy, new-onset diabetes, and cardiovascular disease. Int J Clin Pract. 2009 Apr; 63(4):656-66.
    View in: PubMed
    Score: 0.236
  11. All thiazide-like diuretics are not chlorthalidone: putting the ACCOMPLISH study into perspective. J Clin Hypertens (Greenwich). 2009 Jan; 11(1):5-10.
    View in: PubMed
    Score: 0.234
  12. Rationale for fixed-dose combination therapy to reach lower blood pressure goals. South Med J. 2008 Sep; 101(9):918-24.
    View in: PubMed
    Score: 0.229
  13. Shifting paradigms in defining and treating hypertension: addressing global risk with combination therapy. J Clin Hypertens (Greenwich). 2008 Jan; 10(1 Suppl 1):2-3.
    View in: PubMed
    Score: 0.218
  14. Fixed-dose combination therapy in the treatment of hypertension: ready for prime time. South Med J. 2007 Apr; 100(4):343-4.
    View in: PubMed
    Score: 0.207
  15. The importance of early antihypertensive efficacy: the role of angiotensin II receptor blocker therapy. J Hum Hypertens. 2006 Mar; 20(3):169-75.
    View in: PubMed
    Score: 0.192
  16. Treating the cardiometabolic syndrome: an opportunity to provide comprehensive cardiovascular risk reduction. J Cardiometab Syndr. 2006; 1(5):358-61.
    View in: PubMed
    Score: 0.190
  17. Analysis of recent papers in hypertension. J Clin Hypertens (Greenwich). 2004 Feb; 6(2):96-101.
    View in: PubMed
    Score: 0.167
  18. Optimizing antihypertensive treatment in clinical practice. Am J Hypertens. 2003 Sep; 16(9 Pt 2):13S-17S.
    View in: PubMed
    Score: 0.162
  19. How We Got Where We Are in Blood Pressure Targets. Curr Hypertens Rep. 2021 06 10; 23(6):33.
    View in: PubMed
    Score: 0.139
  20. Uncontrolled Hypertension in an Elderly Man on Multiple Antihypertensive Drugs. Hypertension. 2020 12; 76(6):1658-1663.
    View in: PubMed
    Score: 0.133
  21. Combination agents as a means of improving adherence and other aspects of the sixth Joint National Committee Report. South Med J. 2000 May; 93(5):534-6.
    View in: PubMed
    Score: 0.128
  22. Orthostatic Hypotension in the ACCORD (Action to Control Cardiovascular Risk in Diabetes) Blood Pressure Trial: Prevalence, Incidence, and Prognostic Significance. Hypertension. 2016 10; 68(4):888-95.
    View in: PubMed
    Score: 0.099
  23. Cardiovascular Outcomes According to Systolic Blood Pressure in Patients With and Without Diabetes: An ACCOMPLISH Substudy. J Clin Hypertens (Greenwich). 2016 Apr; 18(4):299-307.
    View in: PubMed
    Score: 0.097
  24. Characteristics and long-term follow-up of participants with peripheral arterial disease during ALLHAT. J Gen Intern Med. 2014 Nov; 29(11):1475-83.
    View in: PubMed
    Score: 0.088
  25. Recent clinical trials. J Am Soc Hypertens. 2014 Oct; 8(10):770-4; quiz 775-6.
    View in: PubMed
    Score: 0.086
  26. Analysis of recent papers in hypertension. Initial combination therapy provides more prompt blood pressure control and reduces cardiovascular events but remains underutilized. J Clin Hypertens (Greenwich). 2013 Aug; 15(8):523-5.
    View in: PubMed
    Score: 0.079
  27. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med. 2010 Apr 29; 362(17):1575-85.
    View in: PubMed
    Score: 0.064
  28. Plasma Renin test-guided drug treatment algorithm for correcting patients with treated but uncontrolled hypertension: a randomized controlled trial. Am J Hypertens. 2009 Jul; 22(7):792-801.
    View in: PubMed
    Score: 0.060
  29. Blood pressure control by drug group in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). J Clin Hypertens (Greenwich). 2008 Oct; 10(10):751-60.
    View in: PubMed
    Score: 0.058
  30. Clinical outcomes by race in hypertensive patients with and without the metabolic syndrome: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Arch Intern Med. 2008 Jan 28; 168(2):207-17.
    View in: PubMed
    Score: 0.055
  31. Analysis of recent papers in hypertension. J Clin Hypertens (Greenwich). 2007 May; 9(5):396.
    View in: PubMed
    Score: 0.052
  32. Management of global risk across the continuum of hypertensive heart disease. J Clin Hypertens (Greenwich). 2006 Aug; 8(8 Suppl 2):21-30; quiz 39-40.
    View in: PubMed
    Score: 0.049
  33. The role of existing and newer calcium channel blockers in the treatment of hypertension. J Clin Hypertens (Greenwich). 2004 Nov; 6(11):621-29; quiz 630-1.
    View in: PubMed
    Score: 0.044
  34. Hypertension curriculum review. The importance of systolic blood pressure elevation in elderly persons. J Clin Hypertens (Greenwich). 2004 Aug; 6(8):461-5.
    View in: PubMed
    Score: 0.043
  35. Cardiovascular outcomes using doxazosin vs. chlorthalidone for the treatment of hypertension in older adults with and without glucose disorders: a report from the ALLHAT study. J Clin Hypertens (Greenwich). 2004 Mar; 6(3):116-25.
    View in: PubMed
    Score: 0.042
  36. A statewide primary care approach to cardiovascular risk factor control in high-risk diabetic and nondiabetic patients with hypertension. J Clin Hypertens (Greenwich). 2004 Jan; 6(1):18-25.
    View in: PubMed
    Score: 0.041
  37. Analysis of recent papers in hypertension. Need for more aggressive blood pressure control in diabetes. J Clin Hypertens (Greenwich). 2003 Sep-Oct; 5(5):352-3.
    View in: PubMed
    Score: 0.040
  38. Systolic blood pressure elevation: it's where the action is. Drugs Aging. 2003; 20(4):287-8.
    View in: PubMed
    Score: 0.039
  39. Hypertension in the elderly: a review of the importance of systolic blood pressure elevation. J Clin Hypertens (Greenwich). 2002 Mar-Apr; 4(2):108-12, 119.
    View in: PubMed
    Score: 0.036
  40. Hypertension 2001: pearls for the clinician. South Med J. 2001 Nov; 94(11):1054-7.
    View in: PubMed
    Score: 0.036
  41. Baseline characteristics of the diabetic participants in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Diabetes Care. 2001 Apr; 24(4):654-8.
    View in: PubMed
    Score: 0.034
  42. Mortality and morbidity during and after the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. J Clin Hypertens (Greenwich). 2012 Jan; 14(1):20-31.
    View in: PubMed
    Score: 0.018
  43. Highly interactive multi-session programs impact physician behavior on hypertension management: outcomes of a new CME model. J Clin Hypertens (Greenwich). 2011 Feb; 13(2):97-105.
    View in: PubMed
    Score: 0.017
  44. Combination therapy in hypertension. J Am Soc Hypertens. 2010 Jan-Feb; 4(1):42-50.
    View in: PubMed
    Score: 0.016
  45. Does prehypertension represent an increased risk for incident hypertension and adverse cardiovascular outcome? Hypertension. 2009 Nov; 54(5):954-5.
    View in: PubMed
    Score: 0.015
  46. Rationale and design for the blood pressure intervention of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Am J Cardiol. 2007 Jun 18; 99(12A):44i-55i.
    View in: PubMed
    Score: 0.013
  47. Hypertension and heart failure. Roundtable discussion. J Clin Hypertens (Greenwich). 2004 Jun; 6(6):326-32.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.